1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.22%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
64.11%
Gross profit growth at 75-90% of MAXN's 73.39%. Bill Ackman would demand operational improvements to match competitor gains.
165.49%
EBIT growth above 1.5x MAXN's 71.83%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
49.95%
Operating income growth at 75-90% of MAXN's 66.50%. Bill Ackman would demand a plan to enhance operating leverage.
245.39%
Net income growth above 1.5x MAXN's 73.10%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
325.00%
EPS growth of 325.00% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
316.67%
Diluted EPS growth above 1.5x MAXN's 73.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
8.51%
Share change of 8.51% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
17.51%
Diluted share change of 17.51% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
105.32%
OCF growth 1.25-1.5x MAXN's 93.92%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
53.59%
FCF growth 50-75% of MAXN's 91.23%. Martin Whitman would see if structural disadvantages exist in generating free cash.
251.78%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
251.78%
Positive 5Y CAGR while MAXN is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
283.50%
3Y revenue/share CAGR above 1.5x MAXN's 7.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-97.12%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-97.12%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-56.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
143.82%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
143.82%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
87.49%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.40%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
96.93%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-23.39%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
16.24%
Positive asset growth while MAXN is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.98%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
43.10%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-13.03%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
0.79%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.